Skip to main content
Top
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain)

Authors: Montserrat Rue, Misericordia Carles, Ester Vilaprinyo, Montserrat Martinez-Alonso, Josep-Alfons Espinas, Roger Pla, Pilar Brugulat

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

In Catalonia (Spain) breast cancer mortality has declined since the beginning of the 1990s. The dissemination of early detection by mammography and the introduction of adjuvant treatments are among the possible causes of this decrease, and both were almost coincident in time. Thus, understanding how these procedures were incorporated into use in the general population and in women diagnosed with breast cancer is very important for assessing their contribution to the reduction in breast cancer mortality. In this work we have modeled the dissemination of periodic mammography and described repeat mammography behavior in Catalonia from 1975 to 2006.

Methods

Cross-sectional data from three Catalan Health Surveys for the calendar years 1994, 2002 and 2006 was used. The dissemination of mammography by birth cohort was modeled using a mixed effects model and repeat mammography behavior was described by age and survey year.

Results

For women born from 1938 to 1952, mammography clearly had a period effect, meaning that they started to have periodic mammograms at the same calendar years but at different ages. The age at which approximately 50% of the women were receiving periodic mammograms went from 57.8 years of age for women born in 1938–1942 to 37.3 years of age for women born in 1963–1967. Women in all age groups experienced an increase in periodic mammography use over time, although women in the 50–69 age group have experienced the highest increase. Currently, the target population of the Catalan Breast Cancer Screening Program, 50–69 years of age, is the group that self-reports the highest utilization of periodic mammograms, followed by the 40–49 age group. A higher proportion of women of all age groups have annual mammograms rather than biennial or irregular ones.

Conclusion

Mammography in Catalonia became more widely implemented during the 1990s. We estimated when cohorts initiated periodic mammograms and how frequently women are receiving them. These two pieces of information will be entered into a cost-effectiveness model of early detection in Catalonia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Levi F, Lucchini F, Negri E, La Vecchia C: The fall in breast cancer mortality in Europe. Eur J Cancer. 2001, 37: 1409-1412. 10.1016/S0959-8049(01)00144-7.CrossRefPubMed Levi F, Lucchini F, Negri E, La Vecchia C: The fall in breast cancer mortality in Europe. Eur J Cancer. 2001, 37: 1409-1412. 10.1016/S0959-8049(01)00144-7.CrossRefPubMed
2.
go back to reference Levi F, Lucchini F, Negri E, La Vecchia C: Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007, 18: 593-595. 10.1093/annonc/mdl437.CrossRefPubMed Levi F, Lucchini F, Negri E, La Vecchia C: Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007, 18: 593-595. 10.1093/annonc/mdl437.CrossRefPubMed
3.
go back to reference Botha JL, Bray F, Sankila R, Parkin DM: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003, 39: 1718-1729. 10.1016/S0959-8049(03)00118-7.CrossRefPubMed Botha JL, Bray F, Sankila R, Parkin DM: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003, 39: 1718-1729. 10.1016/S0959-8049(03)00118-7.CrossRefPubMed
4.
go back to reference Fernandez E, Gonzalez JR, Maria Borras J, Sanchez V, Moreno V, Peris M: Trends in cancer mortality in Catalonia (1975–1998). Med Clin (Barc). 2001, 116: 605-609.CrossRef Fernandez E, Gonzalez JR, Maria Borras J, Sanchez V, Moreno V, Peris M: Trends in cancer mortality in Catalonia (1975–1998). Med Clin (Barc). 2001, 116: 605-609.CrossRef
5.
go back to reference Feuer EJ: Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem. J Natl Cancer Inst Monogr. 2006, 2-6. 36 Feuer EJ: Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem. J Natl Cancer Inst Monogr. 2006, 2-6. 36
6.
go back to reference Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ: Modeling the dissemination of mammography in the United States. Cancer Causes Control. 2005, 16: 701-712. 10.1007/s10552-005-0693-8.CrossRefPubMed Cronin KA, Yu B, Krapcho M, Miglioretti DL, Fay MP, Izmirlian G, Ballard-Barbash R, Geller BM, Feuer EJ: Modeling the dissemination of mammography in the United States. Cancer Causes Control. 2005, 16: 701-712. 10.1007/s10552-005-0693-8.CrossRefPubMed
7.
go back to reference Cronin KA, Mariotto AB, Clarke LD, Feuer EJ: Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality. J Natl Cancer Inst Monogr. 2006, 26-29. 36 Cronin KA, Mariotto AB, Clarke LD, Feuer EJ: Additional common inputs for analyzing impact of adjuvant therapy and mammography on U.S. mortality. J Natl Cancer Inst Monogr. 2006, 26-29. 36
8.
go back to reference Cronin KA, Feuer EJ, Clarke LD, Plevritis SK: Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis. J Natl Cancer Inst Monogr. 2006, 112-121. 36 Cronin KA, Feuer EJ, Clarke LD, Plevritis SK: Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case analysis. J Natl Cancer Inst Monogr. 2006, 112-121. 36
10.
go back to reference Generalitat de Catalunya, Departament de Sanitat i Seguretat Social: Enquesta de Salut de Catalunya, 1994. 1998, Barcelona: Servei Català de la Salut Generalitat de Catalunya, Departament de Sanitat i Seguretat Social: Enquesta de Salut de Catalunya, 1994. 1998, Barcelona: Servei Català de la Salut
11.
go back to reference Generalitat de Catalunya, Departament de Sanitat i Seguretat Social: La salut i els serveis sanitaris a Catalunya. La visió dels ciutadans l'any 2002. 2003, Barcelona: Generalitat de Catalunya Generalitat de Catalunya, Departament de Sanitat i Seguretat Social: La salut i els serveis sanitaris a Catalunya. La visió dels ciutadans l'any 2002. 2003, Barcelona: Generalitat de Catalunya
14.
go back to reference Pinheiro J, Bates D: Mixed-effects models in S and S-plus. 2000, New York: Springer-Verlag, 2CrossRef Pinheiro J, Bates D: Mixed-effects models in S and S-plus. 2000, New York: Springer-Verlag, 2CrossRef
16.
go back to reference Bancej CM, Maxwell CJ, Snider J: Inconsistent self-reported mammography history: findings from the National Population Health Survey longitudinal cohort. BMC Health Serv Res. 2004, 4: 32-10.1186/1472-6963-4-32.CrossRefPubMedPubMedCentral Bancej CM, Maxwell CJ, Snider J: Inconsistent self-reported mammography history: findings from the National Population Health Survey longitudinal cohort. BMC Health Serv Res. 2004, 4: 32-10.1186/1472-6963-4-32.CrossRefPubMedPubMedCentral
17.
go back to reference Rivera S, Vernon SW, Tiro JA, Coan S, Del Junco D, Chan W, Coker A: Test-retest reliability of self-reported mammography in women veterans. Prev Med. 2006, 42: 320-326. 10.1016/j.ypmed.2005.12.001.CrossRefPubMed Rivera S, Vernon SW, Tiro JA, Coan S, Del Junco D, Chan W, Coker A: Test-retest reliability of self-reported mammography in women veterans. Prev Med. 2006, 42: 320-326. 10.1016/j.ypmed.2005.12.001.CrossRefPubMed
18.
go back to reference Rohlfs I, Borrell C, Plasencia A, Pasarin I: Social inequalities and realisation of opportunistic screening mammographies in Barcelona (Spain). J Epidemiol Community Health. 1998, 52: 205-206.CrossRefPubMedPubMedCentral Rohlfs I, Borrell C, Plasencia A, Pasarin I: Social inequalities and realisation of opportunistic screening mammographies in Barcelona (Spain). J Epidemiol Community Health. 1998, 52: 205-206.CrossRefPubMedPubMedCentral
19.
go back to reference Segura JM, Castells X, Casamitjana M, Macia F, Ferrer F: Utilization of screening mammography as a preventive practice prior to initiating a population-based breast cancer screening program. J Clin Epidemiol. 2000, 53: 595-603. 10.1016/S0895-4356(99)00201-2.CrossRefPubMed Segura JM, Castells X, Casamitjana M, Macia F, Ferrer F: Utilization of screening mammography as a preventive practice prior to initiating a population-based breast cancer screening program. J Clin Epidemiol. 2000, 53: 595-603. 10.1016/S0895-4356(99)00201-2.CrossRefPubMed
20.
21.
go back to reference Borras JM, Guillen M, Sanchez V, Junca S, Vicente R: Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev. 1999, 8: 427-434.CrossRefPubMed Borras JM, Guillen M, Sanchez V, Junca S, Vicente R: Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev. 1999, 8: 427-434.CrossRefPubMed
22.
go back to reference Rogers E: Diffusion of innovations. 1995, New York: Free Press, 4 Rogers E: Diffusion of innovations. 1995, New York: Free Press, 4
23.
go back to reference O'Brien RM, Hudson K, Stockard J: A mixed model estimation of age, period, and cohort effects. Soc Methods Res. 2008, 36: 402-428. 10.1177/0049124106290392.CrossRef O'Brien RM, Hudson K, Stockard J: A mixed model estimation of age, period, and cohort effects. Soc Methods Res. 2008, 36: 402-428. 10.1177/0049124106290392.CrossRef
24.
go back to reference Masuet C, Seculi E, Brugulat P, Tresserras R: The practice of preventive mammography in Catalonia [Spain]: a step forward. Gac Sanit. 2004, 18: 321-325.CrossRefPubMed Masuet C, Seculi E, Brugulat P, Tresserras R: The practice of preventive mammography in Catalonia [Spain]: a step forward. Gac Sanit. 2004, 18: 321-325.CrossRefPubMed
25.
go back to reference EACP programme "Europe Against Cancer Programme": European Guideline for Quality Assurance in Mammography Screening. 1996, Luxemburg: European Comission, 2 EACP programme "Europe Against Cancer Programme": European Guideline for Quality Assurance in Mammography Screening. 1996, Luxemburg: European Comission, 2
26.
go back to reference Bare ML, Montes J, Florensa R, Sent'is M, Donoso L: Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev. 2003, 12: 487-494. 10.1097/00008469-200312000-00007.CrossRefPubMed Bare ML, Montes J, Florensa R, Sent'is M, Donoso L: Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev. 2003, 12: 487-494. 10.1097/00008469-200312000-00007.CrossRefPubMed
27.
go back to reference Borrell C, Rohlfs I, Ferrando J, Pasarin MI, Dominguez-Berjon F, Plasencia A: Social inequalities in perceived health and the use of health services in a southern European urban area. Int J Health Serv. 1999, 29: 743-764. 10.2190/MVW3-PJ88-LYG4-EWQT.CrossRefPubMed Borrell C, Rohlfs I, Ferrando J, Pasarin MI, Dominguez-Berjon F, Plasencia A: Social inequalities in perceived health and the use of health services in a southern European urban area. Int J Health Serv. 1999, 29: 743-764. 10.2190/MVW3-PJ88-LYG4-EWQT.CrossRefPubMed
Metadata
Title
Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain)
Authors
Montserrat Rue
Misericordia Carles
Ester Vilaprinyo
Montserrat Martinez-Alonso
Josep-Alfons Espinas
Roger Pla
Pilar Brugulat
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-336

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine